Baxter Reports Double-Digit EPS Growth for Third Quarter
Baxter International Inc. (NYSE:BAX) today reported solid financial results for the third quarter of 2009, and provided…
Baxter International Inc. (NYSE:BAX) today reported solid financial results for the third quarter of 2009, and provided…
Once-a-day tablet Daxas® (roflumilast) is a first-in-class treatment under development targeting inflammation, the under…
. - New drug application filed for United States - Treatment aimed at patients with symptomatic Chronic Obstructive Pu…